BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37191829)

  • 1. The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis.
    Denouel A; Brandel JP; Seilhean D; Laplanche JL; Elbaz A; Haik S
    Eur J Epidemiol; 2023 Jul; 38(7):757-764. PubMed ID: 37191829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center.
    Karch A; Raddatz LM; Ponto C; Hermann P; Summers D; Zerr I
    J Neurol; 2014 May; 261(5):877-83. PubMed ID: 24570280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms.
    Denouel A; Brandel JP; Peckeu-Abboud L; Seilhean D; Bouaziz-Amar E; Quadrio I; Oudart JB; Lehmann S; Bellecave P; Laplanche JL; Haik S
    Euro Surveill; 2023 Dec; 28(50):. PubMed ID: 38099349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease.
    Watson N; Hermann P; Ladogana A; Denouel A; Baiardi S; Colaizzo E; Giaccone G; Glatzel M; Green AJE; Haïk S; Imperiale D; MacKenzie J; Moda F; Smith C; Summers D; Tiple D; Vaianella L; Zanusso G; Pocchiari M; Zerr I; Parchi P; Brandel JP; Pal S
    JAMA Netw Open; 2022 Jan; 5(1):e2146319. PubMed ID: 35099544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: an epidemiologic model-based study.
    Pillonel J; Brandel JP; Léon L; Salomon D; Haïk S; Capek I; Vaillant V; Coste J; Alpérovitch A
    Transfusion; 2012 Jun; 52(6):1290-5. PubMed ID: 22128904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992-7.
    d'Aignaux JH; Laplanche JL; Delasnerie-Lauprêtre N; Brandel JP; Peoc'h K; Salomon D; Hauw JJ; Alpérovitch A
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):787-9. PubMed ID: 10811709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients.
    Orrù CD; Soldau K; Cordano C; Llibre-Guerra J; Green AJ; Sanchez H; Groveman BR; Edland SD; Safar JG; Lin JH; Caughey B; Geschwind MD; Sigurdson CJ
    mBio; 2018 Nov; 9(6):. PubMed ID: 30459197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First participant diagnosed with Creutzfeldt-Jakob disease in the population-based Rotterdam Study was classified with mild cognitive impairment.
    Karamujić-Čomić H; Rozemuller AJM; Ikram MA; van Duijn CM
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33782059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic Creutzfeldt-Jakob Disease: A Retrospective Analysis of 104 Cases.
    Qi C; Zhang JT; Zhao W; Xing XW; Yu SY
    Eur Neurol; 2020; 83(1):65-72. PubMed ID: 32344417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.
    Mead S; Burnell M; Lowe J; Thompson A; Lukic A; Porter MC; Carswell C; Kaski D; Kenny J; Mok TH; Bjurstrom N; Franko E; Gorham M; Druyeh R; Wadsworth JD; Jaunmuktane Z; Brandner S; Hyare H; Rudge P; Walker AS; Collinge J
    JAMA Neurol; 2016 Apr; 73(4):447-55. PubMed ID: 26902324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
    Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004.
    Ruegger J; Stoeck K; Amsler L; Blaettler T; Zwahlen M; Aguzzi A; Glatzel M; Hess K; Eckert T
    BMC Public Health; 2009 Jan; 9():18. PubMed ID: 19144172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory features of 14 young Chinese probable sCJD patients.
    Shi Q; Xiao K; Chen C; Zhou W; Gao C; Wang J; Zhang BY; Wang Y; Dong XP
    Prion; 2017 Mar; 11(2):128-135. PubMed ID: 28278113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-white cases of sporadic Creutzfeldt-Jakob disease: A 28 year review of United Kingdom National Surveillance Data.
    Langlands G; Mackenzie J; Graham C; Watson N; Molesworth A; Summers D; Green A; Smith C; Pal S
    J Neurol Sci; 2021 May; 424():117416. PubMed ID: 33839436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.
    Eisenmenger L; Porter MC; Carswell CJ; Thompson A; Mead S; Rudge P; Collinge J; Brandner S; Jäger HR; Hyare H
    JAMA Neurol; 2016 Jan; 73(1):76-84. PubMed ID: 26569479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type.
    Hamaguchi T; Sanjo N; Ae R; Nakamura Y; Sakai K; Takao M; Murayama S; Iwasaki Y; Satoh K; Murai H; Harada M; Tsukamoto T; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1158-1165. PubMed ID: 32839349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.
    Jones E; Hummerich H; Viré E; Uphill J; Dimitriadis A; Speedy H; Campbell T; Norsworthy P; Quinn L; Whitfield J; Linehan J; Jaunmuktane Z; Brandner S; Jat P; Nihat A; How Mok T; Ahmed P; Collins S; Stehmann C; Sarros S; Kovacs GG; Geschwind MD; Golubjatnikov A; Frontzek K; Budka H; Aguzzi A; Karamujić-Čomić H; van der Lee SJ; Ibrahim-Verbaas CA; van Duijn CM; Sikorska B; Golanska E; Liberski PP; Calero M; Calero O; Sanchez-Juan P; Salas A; Martinón-Torres F; Bouaziz-Amar E; Haïk S; Laplanche JL; Brandel JP; Amouyel P; Lambert JC; Parchi P; Bartoletti-Stella A; Capellari S; Poleggi A; Ladogana A; Pocchiari M; Aneli S; Matullo G; Knight R; Zafar S; Zerr I; Booth S; Coulthart MB; Jansen GH; Glisic K; Blevins J; Gambetti P; Safar J; Appleby B; Collinge J; Mead S
    Lancet Neurol; 2020 Oct; 19(10):840-848. PubMed ID: 32949544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic Creutzfeldt-Jakob Disease in the young (50 and below): 10-year review of United Kingdom surveillance.
    Tam J; Centola J; Kurudzhu H; Watson N; MacKenzie J; Leitch M; Hughes T; Green A; Summers D; Barria M; Smith C; Pal S
    J Neurol; 2023 Feb; 270(2):1036-1046. PubMed ID: 36334135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin level is significantly increased in the cerebrospinal fluid of patients with sporadic Creutzfeldt-Jakob disease.
    Chen C; Hu C; Zhou W; Chen J; Shi Q; Xiao K; Wang Y; Dong XP
    Eur J Neurol; 2021 Apr; 28(4):1134-1141. PubMed ID: 33220142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom.
    Urwin P; Thanigaikumar K; Ironside JW; Molesworth A; Knight RS; Hewitt PE; Llewelyn C; Mackenzie J; Will RG
    Emerg Infect Dis; 2017 Jun; 23(6):893-7. PubMed ID: 28516863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.